Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Centessa Pharmaceuticals (CNTA) Return on Equity (2022 - 2025)

Historic Return on Equity for Centessa Pharmaceuticals (CNTA) over the last 4 years, with Q3 2025 value amounting to 0.75%.

  • Centessa Pharmaceuticals' Return on Equity fell 3400.0% to 0.75% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.75%, marking a year-over-year decrease of 3400.0%. This contributed to the annual value of 0.74% for FY2024, which is 2100.0% down from last year.
  • Centessa Pharmaceuticals' Return on Equity amounted to 0.75% in Q3 2025, which was down 3400.0% from 0.63% recorded in Q2 2025.
  • In the past 5 years, Centessa Pharmaceuticals' Return on Equity registered a high of 0.41% during Q3 2024, and its lowest value of 0.75% during Q3 2025.
  • Over the past 4 years, Centessa Pharmaceuticals' median Return on Equity value was 0.61% (recorded in 2022), while the average stood at 0.6%.
  • Its Return on Equity has fluctuated over the past 5 years, first soared by 1800bps in 2024, then plummeted by -3400bps in 2025.
  • Over the past 4 years, Centessa Pharmaceuticals' Return on Equity (Quarter) stood at 0.61% in 2022, then rose by 0bps to 0.61% in 2023, then grew by 14bps to 0.52% in 2024, then tumbled by -43bps to 0.75% in 2025.
  • Its Return on Equity was 0.75% in Q3 2025, compared to 0.63% in Q2 2025 and 0.57% in Q1 2025.